Clinical Trial Detail

NCT ID NCT02064582
Title Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Enzalutamide

Age Groups: senior adult

No variant requirements are available.